{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:33:58Z","timestamp":1787070838603,"version":"build-2736575974"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Topical atropine has been widely used for controlling myopia progression in children, yet its long-term efficacy and safety, including potential intraocular pressure (IOP) elevation, are still being studied. The mydriasis and cyclopegia induced by atropine may reduce traction on the trabecular meshwork, together with pigment released into anterior chamber due to the friction between the iris and lens during pupil dilation, may obstruct and reduce the trabecular outflow. This review first explores postdilation IOP changes across different groups \u2013 healthy individuals, glaucoma patients, and children. The response to pupil dilation varies widely, with IOP potentially increasing or decreasing. Glaucoma patients, whether with open or closed-angle glaucoma, may experience more significant IOP rises postdilation. The second section examines IOP effects in children using topical atropine for myopia, where most of the 25 reviewed studies showed nonsignificant IOP changes, although slight increases were observed in a few. In addition, no alterations in the retinal nerve fiber layer thickness were found. However, the research on children\u2019s IOP under topical atropine is constrained by small sample sizes, cross-sectional studies, brief follow-ups, and often lacks control groups or pretreatment IOP measurements. Given the extended atropine use for myopia and the significant individual variation in IOP response, we recommend routine IOP monitoring for children receiving topical atropine.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-24-00026","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T06:02:26Z","timestamp":1718949746000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Impact of atropine use for myopia control on intraocular pressure in children: A comprehensive review including postpupil dilation intraocular pressure changes"],"prefix":"10.4103","volume":"14","author":[{"given":"Pao-Ju","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hsia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsun","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan"},{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chia","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehn-Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsing-Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/519276a","article-title":"The myopia boom","volume":"519","author":"Dolgin","year":"2015","journal-title":"Nature"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12886-019-1220-0","article-title":"A review on the epidemiology of myopia in school children worldwide","volume":"20","author":"Grzybowski","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.2147\/OPTH.S405202","article-title":"Understanding posterior staphyloma in pathologic myopia:Current overview, new input, and perspectives","volume":"17","author":"Ehongo","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"111092","DOI":"10.1016\/j.biopha.2020.111092","article-title":"Pharmacotherapeutic candidates for myopia:A review","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000501937","article-title":"Significance of outdoor time for myopia prevention:A systematic review and meta-analysis based on randomized controlled trials","volume":"63","author":"Cao","year":"2020","journal-title":"Ophthalmic Res"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bjophthalmol-2019-314675","article-title":"How does spending time outdoors protect against myopia?A review","volume":"104","author":"Lingham","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41433-023-02723-5","article-title":"Optical interventions for myopia control","volume":"38","author":"Logan","year":"2024","journal-title":"Eye (Lond)"},{"key":"R8-20240830","first-page":"405","article-title":"Controlling progression of myopia:Optical and pharmaceutical strategies","volume":"7","author":"Sankaridurg","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.62.5.6","article-title":"IMI prevention of myopia and its progression","volume":"62","author":"Jonas","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/eye.2012.279","article-title":"Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007:A nationwide study","volume":"27","author":"Fang","year":"2013","journal-title":"Eye (Lond)"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","article-title":"Update in myopia and treatment strategy of atropine use in myopia control","volume":"33","author":"Wu","year":"2019","journal-title":"Eye (Lond)"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia:Safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study:Phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years:A randomized clinical trial","volume":"141","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study:A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","article-title":"Efficacy and safety of 8 atropine concentrations for myopia control in children:A network meta-analysis","volume":"129","author":"Ha","year":"2022","journal-title":"Ophthalmology"},{"key":"R18-20240830","first-page":"CD014758","article-title":"Interventions for myopia control in children:A living systematic review and network meta-analysis","volume":"2","author":"Lawrenson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih","year":"1999","journal-title":"J Ocul Pharmacol Ther"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1475-1313.1987.tb01004.x","article-title":"A review of the uses and adverse effects of topical administration of atropine","volume":"7","author":"North","year":"1987","journal-title":"Ophthalmic Physiol Opt"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bjo.2004.045526","article-title":"Multifocal electroretinogram in children on atropine treatment for myopia","volume":"89","author":"Luu","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10633-012-9372-8","article-title":"Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study","volume":"126","author":"Chia","year":"2013","journal-title":"Doc Ophthalmol"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","article-title":"Topical atropine for childhood myopia control:The atropine treatment long-term assessment study","volume":"142","author":"Li","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0000000000000677","article-title":"Biological mechanisms of atropine control of myopia","volume":"46","author":"Upadhyay","year":"2020","journal-title":"Eye Contact Lens"},{"key":"R25-20240830","first-page":"961","article-title":"Systemic atropine and glaucoma","volume":"60","author":"Greenstein","year":"1984","journal-title":"Bull N Y Acad Med"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archopht.1968.03850040244004","article-title":"Cycloplegic-induced intraocular pressure elevations a study of normal and open-angle glaucomatous eyes","volume":"79","author":"Harris","year":"1968","journal-title":"Arch Ophthalmol"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archopht.1971.01000010014003","article-title":"Cycloplegic provocative testing after topical administration of steroids","volume":"86","author":"Harris","year":"1971","journal-title":"Arch Ophthalmol"},{"key":"R28-20240830","first-page":"111","article-title":"Changes in intraocular pressure due to cycloplegia","volume":"24","author":"Velasco","year":"1998","journal-title":"CLAO J"},{"key":"R29-20240830","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1755-3768.1965.tb00343.x","article-title":"Mydriasis-induced pigment liberation in the anterior chamber associated with acute rise in intraocular pressure in open-angle glaucoma","volume":"43","author":"Kristensen","year":"1965","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3109\/02713683.2014.954674","article-title":"The impact of pupillary dilation on intraocular pressure and anterior segment morphology in subjects with and without pseudoexfoliation","volume":"40","author":"Atalay","year":"2015","journal-title":"Curr Eye Res"},{"key":"R31-20240830","first-page":"52","article-title":"Effect of cyclopentolate on the aqueous dynamics in incipient or suspected open-angle glaucoma","volume":"123","author":"Valle","year":"1974","journal-title":"Acta Ophthalmol Suppl"},{"key":"R32-20240830","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41433-022-02215-y","article-title":"Risk of acute angle-closure and changes in intraocular pressure after pupillary dilation in patients with diabetes","volume":"37","author":"Xiong","year":"2023","journal-title":"Eye (Lond)"},{"key":"R33-20240830","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1167\/iovs.08-2745","article-title":"Is routine pupil dilation safe among Asian patients with diabetes?","volume":"50","author":"Tan","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-20240830","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/JCMA.0000000000000794","article-title":"Changes in intraocular pressure after pharmacological pupil dilatation in an elderly Chinese population in Taiwan:The shihpai eye study","volume":"85","author":"Kuang","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"R35-20240830","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.eye.6700146","article-title":"Changes in intraocular pressure following diagnostic mydriasis with cyclopentolate 1%","volume":"16","author":"Hancox","year":"2002","journal-title":"Eye (Lond)"},{"key":"R36-20240830","first-page":"31","article-title":"The influence of tropicamide on intraocular pressure","volume":"7","author":"Portney","year":"1975","journal-title":"Ann Ophthalmol"},{"key":"R37-20240830","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0420.2005.00557.x","article-title":"Intraocular pressure change following application of 1% tropicamide for diagnostic mydriasis","volume":"84","author":"Pukrushpan","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R38-20240830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2415-12-53","article-title":"Changes in intraocular pressure after pharmacologic pupil dilation","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Ophthalmol"},{"key":"R39-20240830","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcjo.2012.07.005","article-title":"Pre- versus post-dilation changes in intraocular pressure:Their clinical significance","volume":"47","author":"Qian","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"R40-20240830","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10792-014-9935-7","article-title":"The change in intraocular pressure after pupillary dilation in eyes with pseudoexfoliation glaucoma, primary open angle glaucoma, and eyes of normal subjects","volume":"35","author":"Atalay","year":"2015","journal-title":"Int Ophthalmol"},{"key":"R41-20240830","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ophtha.2011.08.033","article-title":"Risk of acute angle closure and changes in intraocular pressure after pupillary dilation in Asian subjects with narrow angles","volume":"119","author":"Lavanya","year":"2012","journal-title":"Ophthalmology"},{"key":"R42-20240830","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archopht.1986.01050200091057","article-title":"Intraocular pressure elevation after pupillary dilation in open angle glaucoma","volume":"104","author":"Shaw","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"R43-20240830","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1385\/AO:37:2:069","article-title":"Risk factors for intraocular pressure elevations after pupillary dilation in patients with open angles","volume":"37","author":"Chen","year":"2005","journal-title":"Ann Ophthalmol"},{"key":"R44-20240830","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/bjo.2007.116855","article-title":"The amount of intraocular pressure rise during pharmacological pupillary dilatation is an indicator of the likelihood of future progression of glaucoma","volume":"91","author":"Siam","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R45-20240830","first-page":"233","article-title":"Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma","volume":"70","author":"Nishimoto","year":"1999","journal-title":"J Am Optom Assoc"},{"key":"R46-20240830","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ogla.2022.04.003","article-title":"Acute angle-closure attacks are uncommon in primary angle-closure suspects after pharmacologic mydriasis:The zhongshan angle-closure prevention trial","volume":"5","author":"Friedman","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"R47-20240830","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2021.06.018","article-title":"The Impact of pharmacological dilation on intraocular pressure in primary angle closure suspects","volume":"235","author":"Wang","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R48-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ophtha.2020.07.009","article-title":"Changes in intraocular pressure and angle structure after dilation in primary angle-closure suspects with visually significant cataract","volume":"128","author":"Zhao","year":"2021","journal-title":"Ophthalmology"},{"key":"R49-20240830","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-020-04941-z","article-title":"Determinants of post-mydriatic intraocular pressure in phakic eyes with prevalent angle closure diseases","volume":"259","author":"Ko","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R50-20240830","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/IJG.0000000000000310","article-title":"Comparison of mydriatic provocative and dark room prone provocative tests for anterior chamber angle configuration","volume":"25","author":"Yamada","year":"2016","journal-title":"J Glaucoma"},{"key":"R51-20240830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/IJG.0000000000001506","article-title":"Effect of pharmacological pupil dilatation on angle configuration in untreated primary angle closure suspects:A swept source anterior segment optical coherence tomography study","volume":"29","author":"Narayanaswamy","year":"2020","journal-title":"J Glaucoma"},{"key":"R52-20240830","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tjo.2015.06.001","article-title":"Changes of intraocular pressure and refractive status in children following cycloplegic refraction with 1% cyclopentolate and 1% tropicamide","volume":"5","author":"Hung","year":"2015","journal-title":"Taiwan J Ophthalmol"},{"key":"R53-20240830","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1444-0938.2011.00677.x","article-title":"Transient changes of intraocular pressure and anterior segment configuration after diagnostic mydriasis with 1% tropicamide in children","volume":"95","author":"Tsai","year":"2012","journal-title":"Clin Exp Optom"},{"key":"R54-20240830","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1097\/OPX.0b013e31823ac4c1","article-title":"Does atropine use increase intraocular pressure in myopic children?","volume":"89","author":"Wu","year":"2012","journal-title":"Optom Vis Sci"},{"key":"R55-20240830","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12886-016-0297-y","article-title":"Effects of topical atropine on intraocular pressure and myopia progression:A prospective comparative study","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R56-20240830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/tjo.tjo_45_17","article-title":"Intraocular pressure monitoring by rebound tonometry in children with myopia","volume":"7","author":"Weng","year":"2017","journal-title":"Taiwan J Ophthalmol"},{"key":"R57-20240830","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1080\/02713683.2017.1359846","article-title":"Optic disc parameters of myopic children with atropine treatment","volume":"42","author":"Chan","year":"2017","journal-title":"Curr Eye Res"},{"key":"R58-20240830","doi-asserted-by":"crossref","first-page":"e22745","DOI":"10.1097\/MD.0000000000022745","article-title":"A STROBE-compliant case-control study:Effects of cumulative doses of topical atropine on intraocular pressure and myopia progression","volume":"99","author":"Yu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R59-20240830","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcm10010111","article-title":"Evaluating the effect of topical atropine use for myopia control on intraocular pressure by using machine learning","volume":"10","author":"Wu","year":"2020","journal-title":"J Clin Med"},{"key":"R60-20240830","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.18240\/ijo.2022.09.04","article-title":"Effect of 0.01% atropine eyedrops on intraocular pressure in schoolchildren:A randomized clinical trial","volume":"15","author":"Bukhari","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"R61-20240830","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/jovr.jovr_35_18","article-title":"Intraocular pressure fluctuation:Is it important?","volume":"13","author":"Kim","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"key":"R62-20240830","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ctim.2008.04.007","article-title":"A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial","volume":"16","author":"Liang","year":"2008","journal-title":"Complement Ther Med"},{"key":"R63-20240830","doi-asserted-by":"crossref","first-page":"102094","DOI":"10.1016\/j.clae.2023.102094","article-title":"Comparison of the clinical efficacy of orthokeratology and 0.01% atropine for retardation of myopia progression in myopic children","volume":"47","author":"Zhang","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"R64-20240830","first-page":"1054","article-title":"The impact of clinical atropine use in Taiwanese schoolchildren:Changes in physiological characteristics and visual functions","volume":"8","author":"Kuo","year":"2021","journal-title":"Children (Basel)"},{"key":"R65-20240830","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0161-6420(79)35459-8","article-title":"Role of cyclopegics in progressive myopia","volume":"86","author":"Dyer","year":"1979","journal-title":"Ophthalmology"},{"key":"R66-20240830","first-page":"1859","article-title":"Combination with different anticholinergic eyedrops for the treatment of children myopia","volume":"99","author":"Han","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R67-20240830","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"R68-20240830","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","article-title":"Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia:A 2-year randomised trial","volume":"10","author":"Kinoshita","year":"2020","journal-title":"Sci Rep"},{"key":"R69-20240830","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaapos.2015.04.006","article-title":"Therapeutic effect of atropine 1% in children with low myopia","volume":"19","author":"Yi","year":"2015","journal-title":"J AAPOS"},{"key":"R70-20240830","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7150\/ijms.39365","article-title":"Efficacy and safety of 1% atropine on retardation of moderate myopia progression in Chinese school children","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J Med Sci"},{"key":"R71-20240830","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-0420.2001.790304.x","article-title":"An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression","volume":"79","author":"Shih","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"R72-20240830","doi-asserted-by":"crossref","first-page":"939","DOI":"10.18240\/ijo.2023.06.17","article-title":"0.05% atropine on control of myopia progression in Chinese school children:A randomized 3-year clinical trial","volume":"16","author":"Zhu","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"R73-20240830","doi-asserted-by":"crossref","first-page":"9920002","DOI":"10.1155\/2022\/9920002","article-title":"Comparisons of three methods for myopia control in adolescents","volume":"2022","author":"Du","year":"2022","journal-title":"J Ophthalmol"},{"key":"R74-20240830","doi-asserted-by":"crossref","first-page":"808440","DOI":"10.3389\/fphar.2022.808440","article-title":"Effect of 0.01% atropine on accommodation in myopic teenagers","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"R75-20240830","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jop.2019.0062","article-title":"Use of topical 0.01% atropine for controlling near work-induced transient myopia:A randomized, double-masked, placebo-controlled study","volume":"36","author":"Guo","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"R76-20240830","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ctim.2014.03.004","article-title":"The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control","volume":"22","author":"Cheng","year":"2014","journal-title":"Complement Ther Med"},{"key":"R77-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/jpm13020325","article-title":"Myopia control with low-dose atropine in European children:Six-month results from a randomized, double-masked, placebo-controlled, multicenter study","volume":"13","author":"Hvid-Hansen","year":"2023","journal-title":"J Pers Med"},{"key":"R78-20240830","first-page":"75","article-title":"Retarding progression of myopia with seasonal modification of topical atropine","volume":"5","author":"Lu","year":"2010","journal-title":"J Ophthalmic Vis Res"},{"key":"R79-20240830","doi-asserted-by":"crossref","first-page":"1095495","DOI":"10.3389\/fped.2023.1095495","article-title":"Effect of 0.02% and 0.01% atropine on ocular biometrics:A two-year clinical trial","volume":"11","author":"Wang","year":"2023","journal-title":"Front Pediatr"},{"key":"R80-20240830","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/08164622.2022.2033603","article-title":"Symptoms and ocular findings associated with administration of 0.01% atropine in young adults","volume":"106","author":"Cyphers","year":"2023","journal-title":"Clin Exp Optom"},{"key":"R81-20240830","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.18240\/ijo.2019.08.16","article-title":"Atropine 0.01% eye drops slow myopia progression:A systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"R82-20240830","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1159\/000510779","article-title":"Combined orthokeratology with atropine for children with myopia:A meta-analysis","volume":"64","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"key":"R83-20240830","doi-asserted-by":"crossref","first-page":"e0282286","DOI":"10.1371\/journal.pone.0282286","article-title":"The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia:A meta-analysis","volume":"18","author":"Wang","year":"2023","journal-title":"PLoS One"},{"key":"R84-20240830","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/opo.13029","article-title":"The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia:A meta-analysis","volume":"42","author":"Zheng","year":"2022","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:25Z","timestamp":1787067445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00026","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}